Notably, both cIAP and WEE1 inhibitor drug classes are modulators of the TNFα-NFκB pathway, which regulates proliferation, cell death, and tumor promoting inflammation in HNSCC [57]. This evidence concerns the gene WEE1 and head and neck squamous cell carcinoma.